Health CanadaGeneral Alert
Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel
Published: July 31, 2015Recall ID: 53835Category: generalCountry: Canada
Safety AlertHealth Canada
Canada
Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel
Recalling Firm: Marketed health products
Reason for Recall / Hazard
Product safety
Product Description & Identification
Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel
Additional Source Details
| Field | Value |
|---|---|
| N I D | 53835 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/gluconorm-repaglinide-new-contraindication-concomitant-use-clopidogrel |
| Issue | Product safety |
| Title | Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2015-07-31 |
| Organization | Marketed health products |
Check Other Products In Your Household
Free Safety ToolsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Overview
- Recalling FirmMarketed health products
Recall Hazard Severity
Official Agency AlertCaution (Class III)
📢 Share Warning
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Marketed health products - Gluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel Check if your household is affected: https://therecallfile.com/recalls/gluconorm-repaglinide-new-contraindication-for-concomitant-use-with-cl/CANADA-53835
Join Alertlist
Get instant email updates whenever critical safety recalls like this are published.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.
Spread the WordGluconorm (repaglinide) - New Contraindication for Concomitant Use with Clopidogrel